{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:51Z","timestamp":1785803691454,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08-AR074562"],"award-info":[{"award-number":["K08-AR074562"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00281-022-00918-8","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T21:02:26Z","timestamp":1645131746000},"page":"269-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)"],"prefix":"10.1007","volume":"44","author":[{"given":"Pui Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"issue":"7","key":"918_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65(7):936\u2013941","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"918_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"1","key":"918_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/art.1780260118","volume":"26","author":"KB Elkon","year":"1983","unstructured":"Elkon KB, Sutherland DC, Rees AJ, Hughes GR, Batchelor JR (1983) HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener\u2019s granulomatosis. Arthritis Rheum 26(1):102\u2013105","journal-title":"Arthritis Rheum"},{"issue":"6","key":"918_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jpeds.2007.04.062","volume":"151","author":"F Yalcinkaya","year":"2007","unstructured":"Yalcinkaya F, Ozcakar ZB, Kasapcopur O, Ozturk A, Akar N, Bakkaloglu A, Arisoy N, Ekim M, Ozen S (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151(6):675\u2013678","journal-title":"J Pediatr"},{"issue":"10","key":"918_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. The New England journal of medicine 370(10):921\u201331","journal-title":"The New England journal of medicine"},{"issue":"10","key":"918_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370(10):911\u2013920","journal-title":"N Engl J Med"},{"issue":"9","key":"918_CR7","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","volume":"60","author":"S Cooray","year":"2021","unstructured":"Cooray S, Omyinmi E, Hong Y, Papadopoulou C, Harper L, Al-Abadi E, Goel R, Dubey S, Wood M, Jolles S, Berg S, Ekelund M, Armon K, Eleftheriou D, Brogan PA (2021) Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2). Rheumatol (Oxford) 60(9):4373\u20134378","journal-title":"Rheumatol (Oxford)"},{"issue":"16","key":"918_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, Romeo T, Barham B, Pinto-Patarroyo G, Toro C, Soldatos A, Zhou Q, Deuitch N, Aksentijevich I, Sheldon SL, Kelly S, Man A, Barron K, Hershfield M, Flegel WA, Kastner DL (2019) Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med 380(16):1582\u20131584","journal-title":"N Engl J Med"},{"issue":"9","key":"918_CR9","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA (2016) Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol 68(9):2314\u20132322","journal-title":"Arthritis Rheumatol"},{"key":"918_CR10","doi-asserted-by":"crossref","unstructured":"S. Sahin, A. Adrovic, O. Kasapcopur 2019 A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2, Current opinion in rheumatology","DOI":"10.1097\/BOR.0000000000000669"},{"issue":"5","key":"918_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Van Montfrans","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, Westendorp WF, Bredius RG, Kollen WJ, Scholvinck EH, Legger GE, Meyts I, Liston A, Lichtenbelt KD, Giltay JC, Van Haaften G, De Vries Simons GM, Leavis H, Sanders CJ, Bierings MB, Nierkens S, Van Gijn ME (2016) Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatol (Oxford) 55(5):902\u201310","journal-title":"Rheumatol (Oxford)"},{"issue":"10","key":"918_CR12","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M (2017) ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 76(10):1648\u20131656","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"918_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/art.41549","volume":"73","author":"O Schnappauf","year":"2021","unstructured":"Schnappauf O, Sampaio Moura N, Aksentijevich I, Stoffels M, Ombrello AK, Hoffmann P, Barron K, Remmers EF, Hershfield M, Kelly SJ, Program NCS, Cuthbertson D, Carette S, Chung SA, Forbess L, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Springer JM, Sreih AG, Warrington KJ, Ytterberg SR, Kastner DL, Grayson PC, Merkel PA, C, (2021) Vasculitis Clinical Research, Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2. Arthritis Rheumatol 73(3):512\u2013519","journal-title":"Arthritis Rheumatol"},{"key":"918_CR14","doi-asserted-by":"crossref","unstructured":"A. Sharma, G. Naidu, V. Sharma, S. Jha, A. Dhooria, V. Dhir, P. Bhatia, S. Bhattad, Chengappa, V. Gupta, D.P. Misra, P.P. Chavan, S. Malaviya, R. Dudam, B. Sharma, S. Kumar, R. Bhojwani, P. Gupta, V. Agarwal, K. Sharma, M. Singhal, M. Rathi, R. Nada, R.W. Minz, V. Chaturvedi, A. Aggarwal, R. Handa, A. Grossi, M. Gattorno, Z. Huang, J. Wang, R. Jois, V.S. Negi, R. Khubchandani, S. Jain, J.I. Arostegui, E.P. Chambers, M.S. Hershfield, I. Aksentijevich, Q. Zhou, P.Y. Lee (2020) Deficiency of adenosine deaminase 2 (DADA2) in adults and children: experience from India, Arthritis Rheumatol","DOI":"10.1002\/art.41500"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P (2016) Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr 177:316\u2013320","journal-title":"J Pediatr"},{"issue":"8","key":"918_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, Hubscher K, Rojas Restrepo J, Goldacker S, Warnatz K, Pachlopnik Schmid J, Duppenthaler A, Lougaris V, Uriarte I, Kelly S, Hershfield M, B, (2017) Grimbacher, Screening of 181 Patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol 69(8):1689\u20131700","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"918_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/eji.202048549","volume":"51","author":"F Schena","year":"2021","unstructured":"Schena F, Penco F, Volpi S, Pastorino C, Caorsi R, Kalli F, Fenoglio D, Salis A, Bertoni A, Prigione I, Bocca P, Insalaco A, De Benedetti F, Antonini F, Grossi A, Signa S, Damonte G, Ceccherini I, Filaci G, Traggiai E, Gattorno M (2021) Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients. Eur J Immunol 51(1):206\u2013219","journal-title":"Eur J Immunol"},{"issue":"8","key":"918_CR18","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10875-021-01141-0","volume":"41","author":"JY Yap","year":"2021","unstructured":"Yap JY, Moens L, Lin MW, Kane A, Kelleher A, Toong C, Wu KHC, Sewell WA, Phan TG, Hollway GE, Enthoven K, Gray PE, Casas-Martin J, Wouters C, De Somer L, Hershfield M, Bucciol G, Delafontaine S, Ma CS, Tangye SG, Meyts I (2021) Intrinsic defects in B cell development and differentiation, T cell exhaustion and altered unconventional T cell generation characterize human adenosine deaminase type 2 deficiency. J Clin Immunol 41(8):1915\u20131935","journal-title":"J Clin Immunol"},{"issue":"6","key":"918_CR19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","volume":"145","author":"PY Lee","year":"2020","unstructured":"Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, Alosaimi MF, Stafstrom K, Platt CD, Stauber T, Raz S, Tirosh I, Weiss A, Jordan MB, Krupski C, Eleftheriou D, Brogan P, Sobh A, Baz Z, Lefranc G, Irani C, Kilic SS, El-Owaidy R, Lokeshwar MR, Pimpale P, Khubchandani R, Chambers EP, Chou J, Geha RS, Nigrovic PA, Zhou Q (2020) Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol 145(6):1664-1672 e10","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"918_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","volume":"41","author":"H Hashem","year":"2021","unstructured":"Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, Muller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, Gungor T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I (2021) Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol 41(7):1633\u20131647","journal-title":"J Clin Immunol"},{"issue":"24","key":"918_CR21","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, Muller I, Babor F, Bredius R, Dalal J, Hsu AP, Holland SM, Hickstein DD, Jolles S, Krance R, Sasa G, Taskinen M, Koskenvuo M, Saarela J, van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Meyts I (2017) Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood 130(24):2682\u20132688","journal-title":"Blood"},{"issue":"1","key":"918_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaci.2021.04.034","volume":"149","author":"H Jee","year":"2022","unstructured":"Jee H, Huang Z, Baxter S, Huang Y, Taylor ML, Henderson LA, Rosenzweig S, Sharma A, Chambers EP, Hershfield MS, Zhou Q, Dedeoglu F, Aksentijevich I, Nigrovic PA, O\u2019Donnell-Luria A, Lee PY (2022) Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. J Allergy Clin Immunol 149(1):379\u2013387","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"918_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.semarthrit.2021.09.001","volume":"51","author":"A Fayand","year":"2021","unstructured":"Fayand A, Chasset F, Boutboul D, Queyrel V, Tieulie N, Guichard I, Dupin N, Franck N, Cohen P, Bessis D, Guenno GL, Kone-Paut I, Belot A, Bonhomme A, Ducharme-Benard S, Grateau G, Sarrabay G, Touitou I, Boursier G, Georgin-Lavialle S (2021) DADA2 diagnosed in adulthood versus childhood: a comparative study on 306 patients including a systematic literature review and 12 French cases. Semin Arthritis Rheum 51(6):1170\u20131179","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"918_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","volume":"26","author":"M Rama","year":"2018","unstructured":"Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Kone-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G (2018) A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Human Gen: EJHG 26(7):960\u2013971","journal-title":"Eur J Human Gen: EJHG"},{"issue":"11","key":"918_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TM Gonzalez Santiago","year":"2015","unstructured":"Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, Gibson LE (2015) Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol 151(11):1230\u20134","journal-title":"JAMA Dermatol"},{"key":"918_CR26","doi-asserted-by":"publisher","first-page":"108411","DOI":"10.1016\/j.clim.2020.108411","volume":"215","author":"Z Huang","year":"2020","unstructured":"Huang Z, Li T, Nigrovic PA, Lee PY (2020) Polyarteritis nodosa and deficiency of adenosine deaminase 2 - shared genealogy generations apart. Clin Immunol 215:108411","journal-title":"Clin Immunol"},{"issue":"3","key":"918_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.semarthrit.2021.04.009","volume":"51","author":"M Kasap Cuceoglu","year":"2021","unstructured":"Kasap Cuceoglu M, Sener S, Batu ED, Kaya Akca U, Demir S, Sag E, Atalay E, Balik Z, Basaran O, Bilginer Y, Ozen S (2021) Systematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum 51(3):559\u2013564","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"918_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3174\/ajnr.A7019","volume":"42","author":"AF Geraldo","year":"2021","unstructured":"Geraldo AF, Caorsi R, Tortora D, Gandolfo C, Ammendola R, Alessio M, Conti G, Insalaco A, Pastore S, Martino S, Ceccherini I, Signa S, Gattorno M, Rossi A, Severino M (2021) Widening the neuroimaging features of adenosine deaminase 2 deficiency. AJNR Am J Neuroradiol 42(5):975\u2013979","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"918_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ajhg.2018.10.027","volume":"103","author":"JC Ulirsch","year":"2018","unstructured":"Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O\u2019Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O\u2019Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT (2018) The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet 103(6):930\u2013947","journal-title":"Am J Hum Genet"},{"issue":"4","key":"918_CR30","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, Hamalainen S, Juntti H, Taskinen M, Ilander M, Andersson EI, Zavialov A, Kaustio M, Keski-Filppula R, Hershfield M, Mustjoki S, Tapiainen T, Seppanen M, Saarela J (2018) ADA2 deficiency: clonal lymphoproliferation in a subset of patients. The Journal of allergy and clinical immunology 141(4):1534\u201315378","journal-title":"The Journal of allergy and clinical immunology"},{"key":"918_CR31","doi-asserted-by":"crossref","unstructured":"E. Van Nieuwenhove, S. Humblet-Baron, L. Van Eyck, L. De Somer, J. Dooley, T. Tousseyn, M. Hershfield, A. Liston, C. Wouters, ADA2 deficiency mimicking idiopathic multicentric Castleman disease, Pediatrics 142(3) (2018).","DOI":"10.1542\/peds.2017-2266"},{"key":"918_CR32","doi-asserted-by":"crossref","unstructured":"A. Alsultan, E. Basher, J. Alqanatish, R. Mohammed, M. Alfadhel (2018) Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis, Pediatr Blood Cancer 65(4)","DOI":"10.1002\/pbc.26912"},{"key":"918_CR33","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3389\/fimmu.2018.02767","volume":"9","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi F, Minniti F, Mauro M, Bortoli M, Balter R, Bonetti E, Zaccaron A, Vitale V, Omrani M, Zoccolillo M, Brigida I, Cicalese MP, Degano M, Hershfield MS, Aiuti A, Bondarenko AV, Chinello M, Cesaro S (2018) ALPS-like phenotype caused by ADA2 deficiency rescued by allogeneic hematopoietic stem cell transplantation. Front Immunol 9:2767","journal-title":"Front Immunol"},{"issue":"1","key":"918_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1073\/pnas.75.1.446","volume":"75","author":"WP Schrader","year":"1978","unstructured":"Schrader WP, Pollara B, Meuwissen HJ (1978) Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci USA 75(1):446\u2013450","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"918_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jinf.2013.05.009","volume":"67","author":"LT Keng","year":"2013","unstructured":"Keng LT, Shu CC, Chen JY, Liang SK, Lin CK, Chang LY, Chang CH, Wang JY, Yu CJ, Lee LN (2013) Evaluating pleural ADA, ADA2, IFN-gamma and IGRA for diagnosing tuberculous pleurisy. J Infect 67(4):294\u2013302","journal-title":"J Infect"},{"issue":"3","key":"918_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ajh.2830370303","volume":"37","author":"JG Niedzwicki","year":"1991","unstructured":"Niedzwicki JG, Mayer KH, Abushanab E, Abernethy DR (1991) Plasma adenosine deaminase2 is a marker for human immunodeficiency virus-1 seroconversion. Am J Hematol 37(3):152\u2013155","journal-title":"Am J Hematol"},{"issue":"5","key":"918_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1182\/blood.V72.5.1627.1627","volume":"72","author":"H Ratech","year":"1988","unstructured":"Ratech H, Martiniuk F, Borer WZ, Rappaport H (1988) Differential expression of adenosine deaminase isozymes in acute leukemia. Blood 72(5):1627\u20131632","journal-title":"Blood"},{"issue":"2","key":"918_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","volume":"79","author":"PY Lee","year":"2020","unstructured":"Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA (2020) Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis 79(2):225\u2013231","journal-title":"Ann Rheum Dis"},{"issue":"Pt 1","key":"918_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BJ20050683","volume":"391","author":"AV Zavialov","year":"2005","unstructured":"Zavialov AV, Engstrom A (2005) Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J 391(Pt 1):51\u201357","journal-title":"Biochem J"},{"issue":"11","key":"918_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-017-0699-8","volume":"19","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kelly SJ, Ganson NJ, Hershfield MS (2017) Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders. Curr Rheumatol Rep 19(11):70","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"918_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood.2019001251","volume":"134","author":"PY Lee","year":"2019","unstructured":"Lee PY (2019) NETing the mechanism of inflammation in DADA2. Blood 134(4):338\u2013339","journal-title":"Blood"},{"issue":"3","key":"918_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, Aksentijevich I, Zavialov AV (2017) Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mole life Sci\u202f: CMLS 74(3):555\u2013570","journal-title":"Cell Mole life Sci : CMLS"},{"issue":"2","key":"918_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Lauvau G (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88(2):279\u2013290","journal-title":"J Leukoc Biol"},{"issue":"16","key":"918_CR44","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1182\/bloodadvances.2020003811","volume":"5","author":"M Zoccolillo","year":"2021","unstructured":"Zoccolillo M, Brigida I, Barzaghi F, Scala S, Hernandez RJ, Basso-Ricci L, Colantuoni M, Pettinato E, Sergi LS, Milardi G, Capasso P, Lombardo A, Gregori S, Sanvito F, Schena F, Cesaro S, Conti F, Pession A, Benedetti F, Gattorno M, Lee PY, Naldini L, Cicalese MP, Aiuti A, Mortellaro A (2021) Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency. Blood Adv 5(16):3174\u20133187","journal-title":"Blood Adv"},{"key":"918_CR45","doi-asserted-by":"crossref","unstructured":"N.T. Deuitch, D. Yang, P.Y. Lee, X. Yu, N.S. Moura, O. Schnappauf, A.K. Ombrello, D. Stone, H.S. Kuehn, S.D. Rosenzweig, P. Hoffmann, C. Cudrici, D.M. Levy, E. Kessler, J.B. Soep, A.D. Hay, A. Dalrymple, Y. Zhang, L. Sun, Q. Zhang, X. Tang, Y. Wu, K. Rao, H. Li, H. Luo, Y. Zhang, J.M. Burnham, M. Boehm, K. Barron, D.L. Kastner, I. Aksentijevich, Q. Zhou (2021) TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2), The Journal of allergy and clinical immunology","DOI":"10.1016\/j.jaci.2021.10.030"},{"key":"918_CR46","doi-asserted-by":"publisher","first-page":"619705","DOI":"10.3389\/fimmu.2020.619705","volume":"11","author":"D Michailidou","year":"2020","unstructured":"Michailidou D, Mustelin T, Lood C (2020) Role of neutrophils in systemic vasculitides. Front Immunol 11:619705","journal-title":"Front Immunol"},{"issue":"2","key":"918_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18(2):134\u2013147","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"918_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ (2016) Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 22(2):146\u2013153","journal-title":"Nat Med"},{"issue":"12","key":"918_CR49","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1136\/annrheumdis-2018-213746","volume":"77","author":"P Mistry","year":"2018","unstructured":"Mistry P, Carmona-Rivera C, Ombrello AK, Hoffmann P, Seto NL, Jones A, Stone DL, Naz F, Carlucci P, Dell\u2019Orso S, Gutierrez-Cruz G, Sun HW, Kastner DL, Aksentijevich I, Kaplan MJ (2018) Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome. Ann Rheum Dis 77(12):1825\u20131833","journal-title":"Ann Rheum Dis"},{"key":"918_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, Kasher PR, Mathieu AL, Malcus C, Demaret J, Fabien N, Collardeau-Frachon S, Mechtouff L, Derex L, Walzer T, Rice GI, Durieu I, Crow YJ (2014) Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J 12:44","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"918_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","volume":"134","author":"C Carmona-Rivera","year":"2019","unstructured":"Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O\u2019Neil LJ, Liu Y, Jacobson KA, Ombrello AK, Stone DL, Tsai WL, Kastner DL, Aksentijevich I, Kaplan MJ, Grayson PC (2019) Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood 134(4):395\u2013406","journal-title":"Blood"},{"issue":"9","key":"918_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hasko","year":"2008","unstructured":"Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7(9):759\u2013770","journal-title":"Nat Rev Drug Discov"},{"issue":"30","key":"918_CR53","doi-asserted-by":"publisher","first-page":"eaba3688","DOI":"10.1126\/sciadv.aba3688","volume":"6","author":"R Dhanwani","year":"2020","unstructured":"Dhanwani R, Takahashi M, Mathews IT, Lenzi C, Romanov A, Watrous JD, Pieters B, Hedrick CC, Benedict CA, Linden J, Nilsson R, Jain M, Sharma S (2020) Cellular sensing of extracellular purine nucleosides triggers an innate IFN-beta response. Sci Adv 6(30):eaba3688","journal-title":"Sci Adv"},{"issue":"5","key":"918_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3899\/jrheum.180045","volume":"46","author":"A Insalaco","year":"2019","unstructured":"Insalaco A, Moneta GM, Pardeo M, Caiello I, Messia V, Bracaglia C, Passarelli C, De Benedetti F (2019) Variable clinical phenotypes and relation of interferon signature with disease activity in ADA2 deficiency. J Rheumatol 46(5):523\u2013526","journal-title":"J Rheumatol"},{"key":"918_CR55","doi-asserted-by":"crossref","unstructured":"H. Nihira, K. Izawa, M. Ito, H. Umebayashi, T. Okano, S. Kajikawa, E. Nanishi, D. Keino, K. Murakami, M. Isa-Nishitani, T. Shiba, Y. Honda, A. Hijikata, T. Yasu, T. Kubota, Y. Hasegawa, Y. Kawashima, N. Nakano, H. Takada, S. Ohga, T. Heike, J. Takita, O. Ohara, S. Takei, M. Takahashi, H. Kanegane, T. Morio, S. Iwaki-Egawa, Y. Sasahara, R. Nishikomori, T. Yasumi (2021) Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation. J Allergy Clin Immunol","DOI":"10.1016\/j.jaci.2021.01.018"},{"issue":"1","key":"918_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12969-017-0193-x","volume":"15","author":"A Skrabl-Baumgartner","year":"2017","unstructured":"Skrabl-Baumgartner A, Plecko B, Schmidt WM, Konig N, Hershfield M, Gruber-Sedlmayr U, Lee-Kirsch MA (2017) Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation. Pediatr Rheumatol Online J 15(1):67","journal-title":"Pediatr Rheumatol Online J"},{"key":"918_CR57","doi-asserted-by":"crossref","unstructured":"O.K. Greiner-Tollersrud, V. Boehler, E. Bartok, M. Krausz, A. Polyzou, J. Schepp, M. Seidl, J.O. Olsen, C.R. Smulski, S. Raieli, K. H\u00fcbscher, E. Trompouki, R. Link, H. Ebersbach, H. Srinivas, M. Marchant, D. Staab, D. Guerini, S. Baasch, P. Henneke, G. Kochs, G. Hartmann, R. Geiger, B. Grimbacher, M. Warncke, M. Proietti (2020) ADA2 is a lysosomal DNase regulating the type-I interferon response. BioRxiv 162990","DOI":"10.1101\/2020.06.21.162990"},{"issue":"7","key":"918_CR58","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1073\/pnas.062059699","volume":"99","author":"M Zurovec","year":"2002","unstructured":"Zurovec M, Dolezal T, Gazi M, Pavlova E, Bryant PJ (2002) Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine. Proc Natl Acad Sci USA 99(7):4403\u20134408","journal-title":"Proc Natl Acad Sci USA"},{"issue":"38","key":"918_CR59","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/onc.2017.145","volume":"36","author":"C Zhu","year":"2017","unstructured":"Zhu C, Chrifi I, Mustafa D, van der Weiden M, Leenen PJM, Duncker DJ, Kros JM, Cheng C (2017) CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma. Oncogene 36(38):5356\u20135368","journal-title":"Oncogene"},{"issue":"5","key":"918_CR60","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","volume":"146","author":"PA Nigrovic","year":"2020","unstructured":"Nigrovic PA, Lee PY, Hoffman HM (2020) Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol 146(5):925\u2013937","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"918_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/JLB.3HI0220-119RR","volume":"110","author":"N Watanabe","year":"2021","unstructured":"Watanabe N, Gao S, Wu Z, Batchu S, Kajigaya S, Diamond C, Alemu L, Raffo DQ, Hoffmann P, Stone D, Ombrello AK, Young NS (2021) Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell RNA sequencing of monocytes. J Leukoc Biol 110(3):409\u2013424","journal-title":"J Leukoc Biol"},{"issue":"8","key":"918_CR62","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/art.41776","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Gorelik M, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA (2021) 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Rheumatol 73(8):1384\u20131393","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"918_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","volume":"14","author":"S Volpi","year":"2016","unstructured":"Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M (2016) Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J 14(1):35","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"918_CR64","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow YJ, Manel N (2015) Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol 15(7):429\u2013440","journal-title":"Nat Rev Immunol"},{"key":"918_CR65","unstructured":"Y.J. Crow (1993) Aicardi-Goutieres Syndrome, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya (Eds.), GeneReviews((R)), Seattle (WA)"},{"issue":"6","key":"918_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, Lee CR, DiMattia MA, Cowen EW, Gonzalez B, Palmer I, DiGiovanna JJ, Biancotto A, Kim H, Tsai WL, Trier AM, Huang Y, Stone DL, Hill S, Kim HJ, St Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland SM, Hughes JD, Mehmet H, Issekutz AC, Raffeld M, McElwee J, Fontana JR, Minniti CP, Moir S, Kastner DL, Gadina M, Steven AC, Wingfield PT, Brooks SR, Rosenzweig SD, Fleisher TA, Deng Z, Boehm M, Paller AS, Goldbach-Mansky R (2014) Activated STING in a vascular and pulmonary syndrome. The New England journal of medicine 371(6):507\u2013518","journal-title":"The New England journal of medicine"},{"issue":"11","key":"918_CR67","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1212\/WNL.0b013e3182872694","volume":"80","author":"A Takanohashi","year":"2013","unstructured":"Takanohashi A, Prust M, Wang J, Gordish-Dressman H, Bloom M, Rice GI, Schmidt JL, Crow YJ, Lebon P, Kuijpers TW, Nagaraju K, Vanderver A (2013) Elevation of proinflammatory cytokines in patients with Aicardi-Goutieres syndrome. Neurology 80(11):997\u20131002","journal-title":"Neurology"},{"issue":"9","key":"918_CR68","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1073\/pnas.0408506102","volume":"102","author":"AK Palucka","year":"2005","unstructured":"Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J (2005) Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 102(9):3372\u20133377","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"918_CR69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1073\/pnas.82.1.188","volume":"82","author":"NC Zoumbos","year":"1985","unstructured":"Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82(1):188\u2013192","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"918_CR70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375\u2013386","journal-title":"Nat Rev Immunol"},{"key":"918_CR71","doi-asserted-by":"publisher","first-page":"631329","DOI":"10.3389\/fped.2021.631329","volume":"9","author":"DM d'Angelo","year":"2021","unstructured":"d\u2019Angelo DM, Di Filippo P, Breda L, Chiarelli F (2021) Type I interferonopathies in children: an overview. Front Pediatr 9:631329","journal-title":"Front Pediatr"},{"issue":"1","key":"918_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nrd.2017.267","volume":"17","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 17(1):78","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"918_CR73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jaci.2018.05.038","volume":"142","author":"PY Lee","year":"2018","unstructured":"Lee PY, Huang Y, Zhou Q, Schnappauf O, Hershfield MS, Li Y, Ganson NJ, Sampaio Moura N, Delmonte OM, Stone SS, Rivkin MJ, Pai SY, Lyons T, Sundel RP, Hsu VW, Notarangelo LD, Aksentijevich I, Nigrovic PA (2018) Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. The Journal of allergy and clinical immunology 142(4):1363-1365 e8","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"12","key":"918_CR74","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1158\/0008-5472.CAN-21-0340","volume":"81","author":"L Wang","year":"2021","unstructured":"Wang L, Londono LM, Cowell J, Saatci O, Aras M, Ersan PG, Serra S, Pei H, Clift R, Zhao Q, Phan KB, Huang L, LaBarre MJ, Li X, Shepard HM, Deaglio S, Linden J, Thanos CD, Sahin O, Cekic C (2021) Targeting adenosine with adenosine deaminase 2 to inhibit growth of solid tumors. Cancer Res 81(12):3319\u20133332","journal-title":"Cancer Res"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-022-00918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00281-022-00918-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-022-00918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T16:04:29Z","timestamp":1651593869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00281-022-00918-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1007\/s00281-022-00918-8","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}